Inactive Instrument
Sector Oramed Pharmaceuticals, Inc. OTC Bulletin Board
Stocks
US68403P1049
Biotechnology & Medical Research
|
End-of-day quote
OTC Bulletin Board
|
||
| - USD | - |
|
| 21/09 | Oramed Pharmaceuticals Inc.(NasdaqCM:ORMP) added to S&P Global BMI Index | CI |
| 01/09 | Lifeward Names Josh Hexter as Interim CEO and Rami Aviram as CFO | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +4.16% | +3.42% | +8.78% | +34.82% | +84.62% | +49.37% | +94.17% | +9.52% | - | 74.31B | |
| +2.76% | -1.60% | -3.98% | +2.68% | +16.46% | +22.80% | +78.53% | +228.53% | +5,432.14% | 56.95B | |
| +0.24% | -1.34% | +2.78% | -0.72% | +7.14% | +3.41% | +34.31% | -17.64% | +209.45% | 48.3B | |
| -4.22% | -2.68% | -4.02% | +4.74% | +149.83% | +327.20% | +694.69% | +619.15% | - | 44.51B | |
| -1.58% | -2.35% | +1.33% | +27.52% | +16.53% | +28.11% | +32.23% | +9.72% | +231.35% | 43.8B | |
| +0.42% | -0.30% | +3.61% | +17.68% | +19.87% | +5.70% | +109.44% | +7.42% | +1,045.55% | 41.12B | |
| -0.11% | +2.30% | -3.03% | -0.65% | +5.81% | +9.19% | +58.68% | +1.77% | +144.64% | 31.07B | |
| +4.51% | +8.43% | +17.73% | +54.15% | +84.16% | +37.27% | +34.97% | -50.85% | - | 28.97B | |
| -1.50% | -2.28% | -2.37% | +2.54% | +1.18% | -8.41% | -13.39% | -59.21% | - | 24.53B | |
| +1.04% | -9.09% | -15.83% | -5.76% | -39.60% | -33.59% | +330.11% | +282.81% | +622.47% | 22.67B | |
| +4.42% | +7.12% | +15.93% | +35.81% | +22.45% | +17.13% | -0.28% | -10.88% | +118.49% | 21.31B | |
| -2.36% | -2.36% | +2.80% | +7.49% | +8.15% | +14.55% | +146.85% | +215.55% | +1,966.83% | 17.32B | |
| -1.26% | +1.73% | -10.31% | -6.57% | +177.32% | +133.17% | +345.74% | +1,714.84% | +655.31% | 15.53B | |
| +0.07% | +0.15% | -15.43% | -14.75% | - | - | - | - | - | 14.98B | |
| +0.79% | -0.08% | +6.34% | +10.83% | +22.02% | +22.53% | +43.82% | -29.15% | +85.21% | 14.7B | |
| -1.18% | -0.66% | +1.02% | +4.92% | +32.92% | +45.61% | +162.20% | +178.76% | +342.03% | 14.58B | |
| +1.75% | +5.01% | -2.33% | -4.21% | +21.88% | -14.87% | +512.82% | - | - | 14.31B | |
| -2.05% | +3.16% | +8.74% | +31.92% | +53.05% | +74.51% | +57.82% | -25.14% | +266.52% | 14.84B | |
| -13.72% | -11.76% | +13.35% | +20.05% | +23.40% | -21.71% | - | - | - | 15.08B | |
| Average | -0.41% | -0.53% | +1.32% | +11.71% | +39.29% | +39.55% | +160.16% | +192.20% | +926.67% | 29.41B | |
| Weighted average by Cap. | +0.30% | -0.70% | +1.78% | +14.04% | +42.58% | +47.45% | +149.52% | +148.97% | +1,309.70% |
- Stock Market
- Stocks
- ORMP Stock
- Stock
- Sector Oramed Pharmaceuticals, Inc.
Select your edition
All financial news and data tailored to specific country editions
